AU2003229753A1 - Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) - Google Patents

Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)

Info

Publication number
AU2003229753A1
AU2003229753A1 AU2003229753A AU2003229753A AU2003229753A1 AU 2003229753 A1 AU2003229753 A1 AU 2003229753A1 AU 2003229753 A AU2003229753 A AU 2003229753A AU 2003229753 A AU2003229753 A AU 2003229753A AU 2003229753 A1 AU2003229753 A1 AU 2003229753A1
Authority
AU
Australia
Prior art keywords
ccr8
therapeutics
diagnostics
diseases associated
chemokine receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003229753A
Inventor
Ulf Bruggemeier
Andreas Geerts
Stefan Golz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2003229753A1 publication Critical patent/AU2003229753A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
AU2003229753A 2002-05-13 2003-04-30 Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) Abandoned AU2003229753A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02010147 2002-05-13
EP02010147.3 2002-05-13
PCT/EP2003/004496 WO2003096020A2 (en) 2002-05-13 2003-04-30 Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)

Publications (1)

Publication Number Publication Date
AU2003229753A1 true AU2003229753A1 (en) 2003-11-11

Family

ID=29414670

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003229753A Abandoned AU2003229753A1 (en) 2002-05-13 2003-04-30 Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)

Country Status (2)

Country Link
AU (1) AU2003229753A1 (en)
WO (1) WO2003096020A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202216771A (en) 2020-06-26 2022-05-01 德商拜耳廠股份有限公司 Ccr8 antibodies for therapeutic applications
JP2023538782A (en) * 2020-08-28 2023-09-11 ハーバー・バイオメド・ユーエス・インコーポレイテッド CCR8 antibody and its uses
CN114891117B (en) * 2022-04-26 2023-09-05 深圳市体内生物医药科技有限公司 Chimeric antigen receptor T cell targeting CCR8 and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039434A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Human g-protein receptor hgber32
AU8669598A (en) * 1997-07-29 1999-02-22 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Chemokine receptor ccr8 dna and uses thereof
JP2001523446A (en) * 1997-11-13 2001-11-27 シェーリング コーポレイション Th2 cell depletion, compositions, methods
WO2001058484A2 (en) * 2000-02-10 2001-08-16 Schering Corporation Novel uses of mammalian ccr8 receptors and related reagents

Also Published As

Publication number Publication date
WO2003096020A2 (en) 2003-11-20
WO2003096020A3 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
AU2003251471A1 (en) Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5)
AU2003214249A1 (en) Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
AU2003214072A1 (en) Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1)
AU2003229767A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)
AU2003229753A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)
AU2003229735A1 (en) Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
AU2003250221A1 (en) Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 6(cxcr6)
AU2003205627A1 (en) Diagnostics and therapeutics for diseases associated with gpr72
AU2003273994A1 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43)
AU2003240589A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4)
AU2003232750A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 11 (ccr11)
AU2003240720A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5)
AU2003233333A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 10 (ccr10)
AU2003250128A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37)
AU2003283427A1 (en) Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1)
AU2003229736A1 (en) Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1)
AU2003206749A1 (en) Diagnostics and therapeutics for diseases associated with the gpr65 receptor
AU2003227751A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (avpr1)
AU2003240639A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3)
AU2003218638A1 (en) Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
AU2003240721A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4)
AU2003245981A1 (en) Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a)
AU2003294728A1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2)
AU2003216866A1 (en) Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
AU2003221502A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 484 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME BAYER HEALTHCARE AG, APPLICATION NO. 2003229753, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003